ANO1 and head and neck squamous cell carcinoma: In head and neck squamous cell carcinoma (HNSCC), ANO1 amplification is associated with poor patient survival, and PDX models have demonstrated that ANO1 inhibition reduces cell migration and invasion [11, 76].